Calmark is a brand that specializes in providing patient-side rapid tests (PNA) specifically for newborns, ensuring a safe journey during the initial stages of life. While most babies experience a smooth transition from birth through the first week of life, some infants require medical care due to various medical conditions. It is essential to quickly understand the health status of these babies.

One of the most common tests conducted on newborns is for bilirubin, a biomarker that, when elevated, causes jaundice. While slight yellowing of the skin is harmless in most cases, significantly elevated bilirubin levels can lead to lasting brain damage if left undetected and untreated. Calmark's mission is to develop reliable and accessible rapid tests for newborns, using patient-side analysis (PNA) technology, to improve the entire healthcare process and make a significant difference, particularly in regions with limited access to hospital laboratories.

Their goal is to become a global leader in PNA diagnostics during the neonatal period, offering all relevant tests for newborns worldwide. Calmark's PNA system comprises a portable, battery-operated instrument called POC-Analyzer and standardized test cassettes for measuring biomarkers in the blood of newborns. Their first CE-marked test, Neo-Bilirubin, measures bilirubin levels to identify infants at risk of jaundice.

Calmark's PNA system provides rapid results within minutes, allowing healthcare providers to make timely decisions with just a small blood sample. By changing the chemistry of the filters in the test cassette, various tests can be developed and analyzed using the same instrument. Calmark aims to ensure that all newborns have a calm start in life by revolutionizing newborn diagnostics